scholarly article | Q13442814 |
P819 | ADS bibcode | 2014PLoSO...985613E |
P356 | DOI | 10.1371/JOURNAL.PONE.0085613 |
P932 | PMC publication ID | 3897457 |
P698 | PubMed publication ID | 24465619 |
P5875 | ResearchGate publication ID | 259919841 |
P50 | author | Douglas F. Nixon | Q44059330 |
Steven G Deeks | Q57425986 | ||
P2093 | author name string | Joseph M McCune | |
Jeffrey N Martin | |||
Brinda Emu | |||
Rebecca Hoh | |||
Walter J Moretto | |||
Melissa Krone | |||
P2860 | cites work | Microbial translocation is a cause of systemic immune activation in chronic HIV infection | Q22251054 |
Laboratory control values for CD4 and CD8 T lymphocytes. Implications for HIV-1 diagnosis | Q24672191 | ||
Two subsets of memory T lymphocytes with distinct homing potentials and effector functions | Q28146072 | ||
Use of a photolabeling technique to identify nonviable cells in fixed homologous or heterologous cell populations | Q30983449 | ||
Cytomegalovirus-specific T cells persist at very high levels during long-term antiretroviral treatment of HIV disease | Q33528999 | ||
AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study | Q33884269 | ||
Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies | Q34139859 | ||
Altered representation of naive and memory CD8 T cell subsets in HIV-infected children | Q34215632 | ||
CD8 naive T cell counts decrease progressively in HIV-infected adults | Q34215781 | ||
Differences in HIV burden and immune activation within the gut of HIV-positive patients receiving suppressive antiretroviral therapy | Q34384134 | ||
Effect of raltegravir-containing intensification on HIV burden and T-cell activation in multiple gut sites of HIV-positive adults on suppressive antiretroviral therapy | Q34384143 | ||
CD4 cell count and the risk of AIDS or death in HIV-Infected adults on combination antiretroviral therapy with a suppressed viral load: a longitudinal cohort study from COHERE | Q35842386 | ||
HIV-1 replication activates CD4+ T cells with specificities for persistent herpes viruses | Q36039280 | ||
Accelerated immune senescence and HIV-1 infection | Q36738887 | ||
Long-term kinetics of T cell production in HIV-infected subjects treated with highly active antiretroviral therapy | Q36974912 | ||
HIV infection-associated immune activation occurs by two distinct pathways that differentially affect CD4 and CD8 T cells | Q37000907 | ||
Phenotype and function of human T lymphocyte subsets: consensus and issues | Q37266382 | ||
Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection | Q37309633 | ||
Treatment intensification with raltegravir in subjects with sustained HIV-1 viraemia suppression: a randomized 48-week study. | Q38476717 | ||
HIV disease progression despite suppression of viral replication is associated with exhaustion of lymphopoiesis | Q41952863 | ||
Lymphocyte subsets and natural killer cell activity in healthy old people and centenarians. | Q42608072 | ||
HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects. | Q43130032 | ||
Phenotypic heterogeneity of antigen-specific CD4 T cells under different conditions of antigen persistence and antigen load | Q43779427 | ||
Expression of costimulatory molecule CD28 on T cells in human immunodeficiency virus type 1 infection: functional and clinical correlations | Q44096645 | ||
Skewed maturation of memory HIV-specific CD8 T lymphocytes | Q45284555 | ||
Reduced thymic output is a major mechanism of immune reconstitution failure in HIV-infected patients after long-term antiretroviral therapy | Q45353124 | ||
Age-related immune dysfunction in health and in human immunodeficiency virus (HIV) disease: association of age and HIV infection with naive CD8+ cell depletion, reduced expression of CD28 on CD8+ cells, and reduced thymic volumes | Q45723070 | ||
Different rates of CD4+ and CD8+ T-cell proliferation in interleukin-2-treated human immunodeficiency virus-positive subjects. | Q45735994 | ||
T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART). | Q45745522 | ||
CD4 percentage, CD4 number, and CD4:CD8 ratio in HIV infection: which to choose and how to use. | Q46405812 | ||
Reference intervals of CD3, CD4, CD8, CD4/CD8, and absolute CD4 values in Asian and Non-Asian populations | Q46768556 | ||
Old age and anti-cytomegalovirus immunity are associated with altered T-cell reconstitution in HIV-1-infected patients. | Q51016644 | ||
Amine reactive dyes: an effective tool to discriminate live and dead cells in polychromatic flow cytometry. | Q51186094 | ||
T-cell dynamics after high-dose chemotherapy in adults: elucidation of the elusive CD8+ subset reveals multiple homeostatic T-cell compartments with distinct implications for immune competence. | Q52013209 | ||
Expansion of cytotoxic CD8+ CD28- T cells in healthy ageing people, including centenarians. | Q52046882 | ||
CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy. | Q53455078 | ||
Immunological abnormalities in asymptomatic homosexual men: correlation with antibody to HTLV-III and sequential changes over two years. | Q55243643 | ||
Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study | Q56539634 | ||
An Immune Risk Phenotype, Cognitive Impairment, and Survival in Very Late Life: Impact of Allostatic Load in Swedish Octogenarian and Nonagenarian Humans | Q56986846 | ||
Shortage of circulating naive CD8(+) T cells provides new insights on immunodeficiency in aging | Q57010350 | ||
HIV Persistence in the Gut Mucosa of HIV-Infected Subjects Undergoing Antiretroviral Therapy Correlates with Immune Activation and Increased Levels of LPS | Q57573965 | ||
Downregulation of CD28 surface antigen on CD4+ and CD8+ T lymphocytes during HIV-1 infection | Q72668437 | ||
Changes in CD8 and CD4 lymphocyte subsets, T cell proliferation responses and non-survival in the very old: the Swedish longitudinal OCTO-immune study | Q77162659 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | HIV | Q15787 |
anti-retroviral agent | Q50430310 | ||
P304 | page(s) | e85613 | |
P577 | publication date | 2014-01-21 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Composition and function of T cell subpopulations are slow to change despite effective antiretroviral treatment of HIV disease | |
P478 | volume | 9 |
Q35801549 | CD4:CD8 ratio as a frontier marker for clinical outcome, immune dysfunction and viral reservoir size in virologically suppressed HIV-positive patients |
Q41609336 | Course and Clinical Significance of CD8+ T-Cell Counts in a Large Cohort of HIV-Infected Individuals |
Q37620588 | Diminished CD103 (αEβ7) Expression on Resident T Cells from the Female Genital Tract of HIV-Positive Women |
Q36402470 | Early Initiation Rather Than Prolonged Duration of Antiretroviral Therapy in HIV Infection Contributes to the Normalization of CD8 T-Cell Counts |
Q34004816 | Early skewed distribution of total and HIV-specific CD8+ T-cell memory phenotypes during primary HIV infection is related to reduced antiviral activity and faster disease progression |
Q98231944 | Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort study |
Q26768147 | Elevation and persistence of CD8 T-cells in HIV infection: the Achilles heel in the ART era |
Q46042029 | HIV and Age Do Not Synergistically Affect Age-Related T cell Markers |
Q38947827 | HIV-related pneumococcal disease prevention in adults. |
Q38981750 | Helicobacter pylori Coinfection Is Associated With Decreased Markers of Immune Activation in ART-Naive HIV-Positive and in HIV-Negative Individuals in Ghana |
Q94539336 | IL-7 induces sCD127 release and mCD127 downregulation in human CD8+ T cells by distinct yet overlapping mechanisms, both of which are impaired in HIV infection |
Q35854044 | Immunosenescence of the CD8(+) T cell compartment is associated with HIV-infection, but only weakly reflects age-related processes of adipose tissue, metabolism, and muscle in antiretroviral therapy-treated HIV-infected patients and controls |
Q33637866 | Impact of illicit opioid use on T cell subsets among HIV-infected adults |
Q54219247 | Long-term trends in CD4 cell counts, CD8 cell counts, and the CD4: CD8 ratio: ART Cohort Collaboration (ART-CC) Study. |
Q59118545 | Monitoring the CD4/CD8 ratio: a promising indicator of disease progression in HIV-infected individuals? |
Q36072424 | Neurocognitive decline in HIV patients is associated with ongoing T-cell activation in the cerebrospinal fluid. |
Q58572549 | Phenotype, Polyfunctionality, and Antiviral Activity of Stimulated CD8 T-Cells From HIV Subjects Who Initiated cART at Different Time-Points After Acute Infection |
Q56988998 | Residual T cell activation and skewed CD8+ T cell memory differentiation despite antiretroviral therapy-induced HIV suppression |
Q59352564 | Safety and Impact of Low-Dose Methotrexate on Endothelial Function and Inflammation in Individuals with Treated Human Immunodeficiency Virus: AIDS Clinical Trials Group Study A5314 |
Q61797436 | Suboptimal Immune Reconstitution among HIV-Infected Saudi Patients following Successful Antiretroviral Treatment |
Q34594094 | The CD8⁺ memory stem T cell (T(SCM)) subset is associated with improved prognosis in chronic HIV-1 infection |
Q40043487 | The effect of HIV infection and HCV viremia on inflammatory mediators and hepatic injury-The Women's Interagency HIV Study |
Q56912967 | The effect of interrupted anti-retroviral treatment on the reconstitution of memory and naive T cells during tuberculosis treatment in HIV patients with active pulmonary tuberculosis |
Q41333604 | Tripterygium wilfordii Hook F extract in cART-treated HIV patients with poor immune response: a pilot study to assess its immunomodulatory effects and safety |
Search more.